New York University · NeuroscienceCognitive Resilience Lab
Thomas M Wisniewski · New York, New York
Research Focus
Dr. Thomas M. Wisniewski's lab at NYU studies the cognitive impacts of COVID-19 on older adults, especially those who may develop Alzheimer's disease or related dementias. They focus on identifying biomarkers in the blood that could predict cognitive decline following COVID-19 infection. By examining patients over time, the lab aims to understand how COVID-19 affects brain health and what factors contribute to cognitive impairment in this population.
COVID-19Alzheimer's Diseasebiomarkerscognitionneurodegenerationinflammationagingneurological disordersSARS-CoV-2
Research Aims
3AIM 01Characterize cognitive and neuropsychological abnormalities in COVID-19 patients over time.
AIM 02Compare plasma AD/ADRD-related biomarkers among different patient groups.
AIM 03Evaluate neuroimaging biomarkers in relation to cognitive outcomes over a multi-year study.
Skills the Lab Values
plasma biomarker analysiscognitive assessmentMRI imagingneuropsychological testingdata collectionclinical trial designstatistical analysispatient enrollmentlongitudinal study methods